141 related articles for article (PubMed ID: 37558635)
1. Comment on: Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease.
Qureshi AA
Pediatr Blood Cancer; 2023 Nov; 70(11):e30618. PubMed ID: 37558635
[No Abstract] [Full Text] [Related]
2. Reply to: Comment on: Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease.
Harris EM; Donado C; Archer NM
Pediatr Blood Cancer; 2024 Jan; 71(1):e30740. PubMed ID: 37877853
[No Abstract] [Full Text] [Related]
3. Ketamine Infusion for Pain Control in Acute Pediatric Sickle Cell Painful Crises.
Hagedorn JM; Monico EC
Pediatr Emerg Care; 2019 Jan; 35(1):78-79. PubMed ID: 27902670
[TBL] [Abstract][Full Text] [Related]
4. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
[TBL] [Abstract][Full Text] [Related]
5. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of ketamine for the management of vaso-occlusive pain in sickle cell disease.
Harris EM; Vilk E; Heeney MM; Solodiuk J; Greco C; Archer NM
Pediatr Blood Cancer; 2021 Jul; 68(7):e28989. PubMed ID: 33788404
[TBL] [Abstract][Full Text] [Related]
7. Low-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell disease.
Neri CM; Pestieau SR; Darbari DS
Paediatr Anaesth; 2013 Aug; 23(8):684-9. PubMed ID: 23565738
[TBL] [Abstract][Full Text] [Related]
8. Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease.
Harris EM; Vilk E; Donado C; Williams A; Heeney MM; Solodiuk J; Greco C; Archer NM
Pediatr Blood Cancer; 2023 May; 70(5):e30254. PubMed ID: 36861789
[TBL] [Abstract][Full Text] [Related]
9. Ketamine for Pain in Sickle Cell Disease Reduces Opioid Usage.
Onyebuchi CO; Chumpitazi CE; Placencia JL; Jackson AN; Jones JL; Torres L; Tubman VN
J Pain Symptom Manage; 2024 Mar; 67(3):e169-e175. PubMed ID: 38000561
[TBL] [Abstract][Full Text] [Related]
10. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
[TBL] [Abstract][Full Text] [Related]
11. Patient characteristics affect the response to ketamine and opioids during the treatment of vaso-occlusive episode-related pain in sickle cell disease.
Nobrega R; Sheehy KA; Lippold C; Rice AL; Finkel JC; Quezado ZMN
Pediatr Res; 2018 Feb; 83(2):445-454. PubMed ID: 28902183
[TBL] [Abstract][Full Text] [Related]
12. Subdissociative intranasal ketamine plus standard pain therapy versus standard pain therapy in the treatment of paediatric sickle cell disease vaso-occlusive crises in resource-limited settings: study protocol for a randomised controlled trial.
Young JR; Sawe HR; Mfinanga JA; Nshom E; Helm E; Moore CG; Runyon MS; Reynolds SL
BMJ Open; 2017 Jul; 7(7):e017190. PubMed ID: 28698351
[TBL] [Abstract][Full Text] [Related]
13. Patient-controlled analgesia in sickle-cell disease painful vaso-occlusive crises: should we add ketamine to morphine?
Zuccarini F; Aoragh A; Maggiore A; Veliziotis I; Kapessidou P
Minerva Anestesiol; 2021 Oct; 87(10):1146-1147. PubMed ID: 33853280
[No Abstract] [Full Text] [Related]
14. Ketamine infusion for sickle cell crisis pain in an adult.
Meals CG; Mullican BD; Shaffer CM; Dangerfield PF; Ramirez RP
J Pain Symptom Manage; 2011 Sep; 42(3):e7-9. PubMed ID: 21854993
[No Abstract] [Full Text] [Related]
15. Use of low-dose ketamine infusion for pediatric patients with sickle cell disease-related pain: a case series.
Zempsky WT; Loiselle KA; Corsi JM; Hagstrom JN
Clin J Pain; 2010 Feb; 26(2):163-7. PubMed ID: 20090444
[TBL] [Abstract][Full Text] [Related]
16. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
Hardwick WE; Givens TG; Monroe KW; King WD; Lawley D
Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant low-dose ketamine for paediatric and young adult sickle cell vaso-occlusive episodes in the emergency department.
Cooper-Sood JB; Hagar W; Marsh A; Hoppe C; Agrawal AK
Br J Haematol; 2022 Jul; 198(1):207-209. PubMed ID: 35396855
[No Abstract] [Full Text] [Related]
18. [Vaso-occlusive pain crises in children with sickle cell anemia].
Fournier-Charrière E
Soins Pediatr Pueric; 2007 Feb; (234):21-6. PubMed ID: 17338413
[No Abstract] [Full Text] [Related]
19. Pupil Size and Reactivity in Pediatric Patients With Sickle Cell Disease.
Mack JM; Frankowski S; Verkamp B; Crary SE; Spray B; Crawley L; Saccente S; Neville KA
J Pediatr Hematol Oncol; 2023 Jan; 45(1):e44-e47. PubMed ID: 34966094
[TBL] [Abstract][Full Text] [Related]
20. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
Casella JF; Barton BA; Kanter J; Black LV; Majumdar S; Inati A; Wali Y; Drachtman RA; Abboud MR; Kilinc Y; Fuh BR; Al-Khabori MK; Takemoto CM; Salman E; Sarnaik SA; Shah N; Morris CR; Keates-Baleeiro J; Raj A; Alvarez OA; Hsu LL; Thompson AA; Sisler IY; Pace BS; Noronha SA; Lasky JL; de Julian EC; Godder K; Thornburg CD; Kamberos NL; Nuss R; Marsh AM; Owen WC; Schaefer A; Tebbi CK; Chantrain CF; Cohen DE; Karakas Z; Piccone CM; George A; Fixler JM; Singleton TC; Moulton T; Quinn CT; de Castro Lobo CL; Almomen AM; Goyal-Khemka M; Maes P; Emanuele M; Gorney RT; Padgett CS; Parsley E; Kronsberg SS; Kato GJ; Gladwin MT
JAMA; 2021 Apr; 325(15):1513-1523. PubMed ID: 33877274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
